Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / Ordinary Shares, par value EUR0.01 per share
-
Shares outstanding
-
83,110,104
-
Total 13F shares
-
21,265,859
-
Share change
-
+21,265,859
-
Total reported value
-
$227,821,381
-
Price per share
-
$10.70
-
Number of holders
-
30
-
Value change
-
+$227,821,381
-
Number of buys
-
30
Institutional Holders of Abivax S.A. - Ordinary Shares, par value EUR0.01 per share (ABVX) as of Q4 2023
As of 31 Dec 2023,
Abivax S.A. - Ordinary Shares, par value EUR0.01 per share (ABVX) was held by
30 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
21,265,859 shares.
The largest 10 holders included
Deep Track Capital, LP, Blackstone Inc., Cormorant Asset Management, LP, COMMODORE CAPITAL LP, GREAT POINT PARTNERS LLC, FRANKLIN RESOURCES INC, TCG Crossover Management, LLC, Nantahala Capital Management, LLC, VR Adviser, LLC, and Samsara BioCapital, LLC.
This page lists
30
institutional shareholders reporting positions in this security
for the Q4 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.